Current management of cancer-associated anorexia and weight loss

Keyphrases

• Cancer Patients 100%
• Anorexia 100%
• Weight Loss 100%
• Current Management 100%
• Cancer-associated 100%
• Pharmacologic Interventions 66%
• Cancer-associated Weight Loss 66%
• Clinical Practice 33%
• Bone Marrow Transplantation 33%
• Stem Cells 33%
• Clinical Benefit 33%
• Lean Tissue 33%
• Patients with Advanced Cancer 33%
• Cancer Cachexia 33%
• Poor Prognosis 33%
• Transplant Patients 33%
• Head-and-neck Cancer 33%
• Patients with Cancer 33%
• Thalidomide 33%
• Eating 33%
• Starvation 33%
• Corticosteroids 33%
• Appetite Loss 33%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 33%
• Adenosine Triphosphate 33%
• Eicosapentaenoic Acid 33%
• Agent Focus 33%
• Nutritional Supplementation 33%
• Progestin Agents 33%

Medicine and Dentistry

• Malignant Neoplasm 100%
• Anorexia 100%
• Advanced Cancer 25%
• Bone Marrow Transplantation 25%
• Adenosine Triphosphate 25%
• Head and Neck Cancer 25%
• Thalidomide 25%
• Supplementation 25%
• Nonsteroid Antiinflammatory Agent 25%
• Icosapentaenoic Acid 25%
• Stem Cell 25%
• Lean Tissue 25%
• Loss of Appetite 25%
• Gestagen 25%
• Diet Supplementation 25%
• Corticosteroid 25%
• Distinct Entity 25%
• Starvation 25%

Nursing and Health Professions

• Malignant Neoplasm 100%
• Anorexia 100%
• Perioperative 25%
• Clinical Practice 25%
• Supplementation 25%
• Loss of Appetite 25%
• Corticosteroid 25%
• Nonsteroid Antiinflammatory Agent 25%
• Bone Marrow Transplantation 25%
• Head and Neck Cancer 25%
• Thalidomide 25%
• Advanced Cancer 25%
• Gestagen 25%
• Adenosine Triphosphate 25%
• Diet Supplementation 25%
• Icosapentaenoic Acid 25%